Medpace Holdings (MEDP) Free Cash Flow (2015 - 2026)

Medpace Holdings (MEDP) has reported Free Cash Flow for 12 consecutive years, with $138.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 3.03% year-over-year to $138.1 million; the trailing twelve-month figure through Jun 2026 stood at $706.7 million (up 21.88% YoY), and the FY2025 full-year result was $681.9 million, up 19.15% from the prior year.
• Free Cash Flow slipped to $138.1 million in Q2 2026 per MEDP's latest filing, from $145.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $235.5 million in Q3 2025 and bottomed at $37.0 million in Q1 2022.
• Historically, Free Cash Flow has averaged $127.0 million across 5 years, with a median of $132.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Free Cash Flow slipped 27.18% in 2022, then jumped 108.58% in 2024.
• Over 5 years, Free Cash Flow stood at $127.4 million in 2022, then gained by 14.88% to $146.4 million in 2023, then advanced by 25.01% to $183.0 million in 2024, then increased by 2.78% to $188.1 million in 2025, then declined by 26.59% to $138.1 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $138.1 million, $145.0 million, and $188.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.